Retinol-binding protein-4 in experimental and clinical metabolic disease (Q37206162)

18 August 2017

1 reference

title

Retinol-binding protein-4 in experimental and clinical metabolic disease (English)

1 reference

18 August 2017

Maximilian von Eynatten

series ordinal

1

object named as

Maximilian von Eynatten

1 reference

18 August 2017

2

Per M Humpert

1 reference

PubMed ID

18598108

18 August 2017

language of work or name

1 reference

1 May 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

3

1 reference

18 August 2017

289-299

1 reference

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

The function of leptin in nutrition, weight, and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinol-binding protein: the transport protein for vitamin A in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

RBP4, an unexpected adipokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

The role of adiponectin in atherosclerosis: do lipids tip the scales?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Fat in the liver and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Adiponectin: a key adipocytokine in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinoic acid metabolism and mechanism of action: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Resistin: yet another adipokine tells us that men are not mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Lipocalins and Insulin Resistance: Etiological Role of Retinol-Binding Protein 4 and Lipocalin-2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Plasma Levels and Adipose Tissue Messenger Ribonucleic Acid Expression of Retinol-Binding Protein 4 Are Reduced during Calorie Restriction in Obese Subjects but Are Not Related to Diet-Induced Changes in Insulin Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.289

21 January 2018

Identifiers

DOI

10.1586/14737159.8.3.289

1 reference

18 August 2017

1 reference

PubMed ID

18598108